Bio-Techne (TECH) Profit After Tax Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.37% |
| Dec 31, 2025 | -3.80% |
| Sep 30, 2025 | 2.72% |
| Jun 30, 2025 | -18.13% |
| Mar 31, 2025 | -9.12% |
| Dec 31, 2024 | -21.84% |
| Sep 30, 2024 | 18.47% |
| Jun 30, 2024 | 19.78% |
| Mar 31, 2024 | 1.90% |
| Dec 31, 2023 | 9.36% |
| Sep 30, 2023 | 23.99% |
| Jun 30, 2023 | 12.55% |
| Mar 31, 2023 | 28.89% |
| Dec 31, 2022 | 0.47% |
| Sep 30, 2022 | 41.42% |
| Jun 30, 2022 | 17.53% |
| Mar 31, 2022 | 22.34% |
| Dec 31, 2021 | 57.37% |
| Sep 30, 2021 | 29.63% |
| Jun 30, 2021 | -11.22% |
| Mar 31, 2021 | 8.43% |
| Dec 31, 2020 | 12.29% |
| Sep 30, 2020 | 8.02% |
| Jun 30, 2020 | 17.45% |
| Mar 31, 2020 | 8.45% |
| Dec 31, 2019 | 29.21% |
| Sep 30, 2019 | -9.64% |
| Jun 30, 2019 | -9.31% |
| Mar 31, 2019 | 7.13% |
| Dec 31, 2018 | -6.87% |
| Sep 30, 2018 | -8.70% |
| Jun 30, 2018 | 7.98% |
| Mar 31, 2018 | -9.83% |
| Dec 31, 2017 | 14.01% |
| Sep 30, 2017 | -9.18% |
| Jun 30, 2017 | 0.27% |
| Mar 31, 2017 | -6.94% |
| Dec 31, 2016 | -21.97% |
| Sep 30, 2016 | -7.30% |
| Jun 30, 2016 | -1.99% |
| Mar 31, 2016 | -0.50% |
| Dec 31, 2015 | -0.52% |
| Sep 30, 2015 | -2.95% |
| Jun 30, 2015 | 0.33% |
| Mar 31, 2015 | -5.59% |
| Dec 31, 2014 | 6.08% |
| Sep 30, 2014 | -2.24% |